Frankfurt - Delayed Quote EUR
Eli Lilly and Company (LLY.F)
709.10
+3.30
+(0.47%)
At close: June 13 at 9:55:56 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 17 | 16 | 28 | 27 |
Avg. Estimate | 14.37B | 15.36B | 59.57B | 71.42B |
Low Estimate | 13.96B | 14.49B | 58.31B | 65.07B |
High Estimate | 14.86B | 16.03B | 62.38B | 79.04B |
Year Ago Sales | 11.3B | 11.44B | 45.04B | 59.57B |
Sales Growth (year/est) | 27.15% | 34.27% | 32.25% | 19.89% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
LLY.F | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.40% | 7.54% | 14.08% |
Upgrades & Downgrades
Maintains | UBS: Buy to Buy | 5/2/2025 |
Downgrade | HSBC: Buy to Reduce | 4/28/2025 |
Initiated | Cantor Fitzgerald: Overweight | 4/22/2025 |
Maintains | Guggenheim: Buy to Buy | 4/14/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 4/9/2025 |
Upgrade | Goldman Sachs: Neutral to Buy | 4/8/2025 |
Related Tickers
D4S.SG Daiichi Sankyo Co Ltd
21.03
-2.32%
4AB.SG AbbVie Inc
165.00
-0.48%
AMGN.BA Amgen Inc.
11,675.00
-0.85%
GS71.F GSK plc
17.70
-2.93%
SANO.VI Sanofi
86.60
+0.06%
PFE.DE Pfizer Inc.
21.39
-0.28%
ZEGA.F AstraZeneca PLC
63.50
0.00%
JNJ.DE Johnson & Johnson
136.02
+0.96%
NOVA.DU Novo Nordisk A/S
69.50
-0.29%
NNO2.VI Novo Nordisk A/S
69.27
-0.16%